Table 2. Demographics of Survivors and Non Survivors .
| Demographics | Survivors (n = 11) | Non Survivors (n = 14) | P value |
|---|---|---|---|
| Age (y) | 52.45 ± 18.67 | 47.36 ± 19.59 | NS |
| Gender, No.(%) | |||
| Male | 7/15 (46.7) | 8/15 (53.3) | NS |
| Female | 4/10 (40) | 6/10 (60) | |
| Diabetes, No.(%) | 3/6 (50) | 3/6 (50) | NS |
| Immunosuppressed, No.(%) | 5/11 (45.4) | 4/14 (28.8) | NS |
| DIVC, No.(%) a | 0.071 | ||
| Yes | 3 (25) | 9 (75) | |
| No | 8 (61.5) | 5 (38.5) | |
| Serum creatinine (µmol/L) | 281 ± 181.4 | 230.1 ± 104.9 | NS |
| Serum albumin (g/L) | 25.45 ± 4.87 | 19.86 ± 4.03 | 0.005 |
| Hemoglobin (g/dL) | 9.6 ± 1.5 | 10.5 ± 2.9 | NS |
| WCCa (x 109) | 16.4 ± 11.2 | 15.0 ± 8.3 | NS |
| CRP (mg/dL) a | 17.28 ± 15.67 | 22.42 ± 14.66 | NS |
| PCT, No.(%) a (ng/dL) | 54.5 ± 38.9 | 37.6 ± 38.6 | NS |
| Duration of CPFA (h) | 5 (1-10) | 3.5 (1.5-10) | NS |
a Abbreviation: CRP; capsular reactive protein, DIVC; disseminated intravascular coagulation, PCT; procalcitonin, WCC; white cell count